In vitro and in vivo pharmacology of S 16474, a novel dual tachykinin NK 1 and NK 2 receptor antagonist

By Robineau P.   Lonchampt M.   Kucharczyk N.   Krause J.E.   Regoli D.   Fauchere J.-L.   Prost J.-F.   Canet E.  

European Journal of Pharmacology, Vol. 294, Iss. 2, 1995-12 ,pp. : 677-684

Elsevier

Access to resources Recommend Favorite

Pharmacology of the peptidomimetic, MEN 11149, a new potent, selective and orally effective tachykinin NK 1 receptor antagonist

By Cirillo R.   Astolfi M.   Conte B.   Lopez G.   Parlani M.   Terracciano R.   Fincham C.I.   Manzini S.  

European Journal of Pharmacology, Vol. 341, Iss. 2, 1998-01 ,pp. : 201-209

Elsevier

Access to resources Recommend Favorite

The dual nature of the tachykinin NK 1 receptor

By Maggi C.A.   Schwartz T.W.  

Trends in Pharmacological Sciences, Vol. 18, Iss. 10, 1997-10 ,pp. : 351-354

Elsevier

Access to resources Recommend Favorite

The human tachykinin NK 1 (short form) and tachykinin NK 4 receptor: a reappraisal

By Page N.M.   Bell N.J.  

European Journal of Pharmacology, Vol. 437, Iss. 1, 2002-02 ,pp. : 27-30

Elsevier

Access to resources Recommend Favorite

Antiemetic effects of sendide, a peptide tachykinin NK 1 receptor antagonist, in the ferret

By Minami M.   Endo T.   Kikuchi K.   Ihira E.   Hirafuji M.   Hamaue N.   Monma Y.   Sakurada T.   Tan-no K.   Kisara K.  

European Journal of Pharmacology, Vol. 363, Iss. 1, 1998-12 ,pp. : 49-55

Elsevier

Access to resources Recommend Favorite